Cargando…
Gene Therapy for Neuropathic Pain by Silencing of TNF-α Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice
Neuropathic pain can be a debilitating condition. Many types of drugs that have been used to treat neuropathic pain have only limited efficacy. Recent studies indicate that pro-inflammatory mediators including tumor necrosis factor α (TNF-α) are involved in the pathogenesis of neuropathic pain. In t...
Autores principales: | Ogawa, Nobuhiro, Kawai, Hiromichi, Terashima, Tomoya, Kojima, Hideto, Oka, Kazuhiro, Chan, Lawrence, Maegawa, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958473/ https://www.ncbi.nlm.nih.gov/pubmed/24642694 http://dx.doi.org/10.1371/journal.pone.0092073 |
Ejemplares similares
-
Gene therapy for neuropathic pain using dorsal root ganglion–targeted helper-dependent adenoviral vectors with GAD67 expression
por: Ogawa, Nobuhiro, et al.
Publicado: (2018) -
Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia
por: Terashima, Tomoya, et al.
Publicado: (2018) -
Lentiviral gene transfer into the dorsal root ganglion of adult rats
por: Yu, Hongwei, et al.
Publicado: (2011) -
Advanced Technology for Gene Delivery with Homing Peptides to Spinal Cord through Systemic Circulation in Mice
por: Terashima, Tomoya, et al.
Publicado: (2019) -
Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
por: Cambon, Karine, et al.
Publicado: (2017)